{"assetClass":"Index","name":"SMI","isin":"CH0009980894","valor":998089,"wkn":"969000","mainCurrency":"","marketValue":{"lastValue":13892.29,"lastDate":"2026-09-14T09:15:08Z","changePercent":0.008494933311651968,"exchange":"SIX SX","triple":"998089,4,1","chartKey":"998089,4,1,0","exchangeClose":"2026-09-11T15:30:17Z","exchangeCloseValue":13775.27},"performance":{"byPeriods":{"FiveYears":0.148291,"Intraday":0.008494933311651968,"OneMonth":-0.034708,"OneWeek":-0.027185,"OneYear":0.13919600000000001,"SixMonths":0.08193099999999999,"TenYears":0.7018000000000001,"ThreeMonths":0.013363,"ThreeYears":0.251649,"TwoYears":0.154015,"YearToDate":0.047011000000000004},"byYears":{"2017":0.128147,"2018":-0.110732,"2019":0.254067,"2020":0.00034500000000000004,"2021":0.19903099999999999,"2022":-0.170781,"2023":0.014496,"2024":0.038552,"2025":0.141385,"2026":0.047011000000000004}},"news":[{"id":"0DBA5600E8D19145","time":"2026-09-11T16:03:43Z","title":"Aktien Europa Schluss: Erholung dank Ölpreisrückgang - US-Inflation stört nicht","follow":false,"isAd":false,"source":"dpa","firstParagraph":null},{"id":"0DBA560076B0FE2F","time":"2026-09-11T09:46:53Z","title":"Aktien Europa: Kursgewinne - US-Inflationsdaten im Fokus","follow":false,"isAd":false,"source":"dpa","firstParagraph":null},{"id":"0DBA5400A0831374","time":"2026-09-10T16:03:11Z","title":"Aktien Europa Schluss: Verluste nach EZB-Entscheid - Inflationssorgen bleiben","follow":false,"isAd":false,"source":"dpa","firstParagraph":null}],"keyFacts":{"close":13775.27,"intradayHigh":13917.55,"intradayLow":13829.94,"isin":"CH0009980894","oneYearHigh":14669.51,"oneYearLow":11867.89,"open":13833.09,"wkn":"969000"},"hasIntradayChart":true,"volatilities":{"180":{"daily":566.9873933695527,"annualized":7606.9341237584,"dailyRelative":0.008060510349844396,"annualizedRelative":0.10814309445355609},"250":{"daily":701.9329499798549,"annualized":11098.534433286919,"dailyRelative":0.007682493837687241,"annualizedRelative":0.12147089318649801},"30":{"daily":236.45840300968115,"annualized":1295.1360124004982,"dailyRelative":0.00655391523347832,"annualizedRelative":0.035897272133528134},"90":{"daily":451.25711228102534,"annualized":4281.000855475141,"dailyRelative":0.006542660149430934,"annualizedRelative":0.06206912408585806}},"topFlops":{"tops":[{"name":"Swisscom","isin":"CH0008742519","relativePerformanceChange":0.031546,"intradayPerformanceChange":0.006928406466512702,"marketValue":654,"rankInIndex":1,"currency":"CHF","assetClass":"Share"},{"name":"Logitech Intl","isin":"CH0025751329","relativePerformanceChange":0.01655,"intradayPerformanceChange":-0.01579778830963665,"marketValue":87.22,"rankInIndex":2,"currency":"EUR","assetClass":"Share"},{"name":"Kuehne+Nagel Int","isin":"CH0025238863","relativePerformanceChange":0.004842,"intradayPerformanceChange":0.015131286159323543,"marketValue":228.1,"rankInIndex":3,"currency":"EUR","assetClass":"Share"}],"flops":[{"name":"CieFinRichemont","isin":"CH0210483332","relativePerformanceChange":-0.056826999999999996,"intradayPerformanceChange":0.012138728323699421,"marketValue":175.1,"rankInIndex":18,"currency":"CHF","assetClass":"Share"},{"name":"Amrize","isin":"CH1430134226","relativePerformanceChange":-0.087402,"intradayPerformanceChange":-0.010247651579846284,"marketValue":34.77,"rankInIndex":19,"currency":"EUR","assetClass":"Share"},{"name":"Novartis","isin":"CH0012005267","relativePerformanceChange":-0.110776,"intradayPerformanceChange":-0.0024924336834609225,"marketValue":112.06,"rankInIndex":20,"currency":"CHF","assetClass":"Share"}]},"analysisTeasers":[{"isin":"CH0126881561","time":"2026-09-14T06:44:49Z","title":"JPMorgan belässt Swiss Re auf 'Underweight'","id":"20260914586790"},{"isin":"CH0012005267","time":"2026-09-11T08:25:19Z","title":"Berenberg senkt Ziel für Novartis auf 105 Franken - 'Hold'","id":"20260911586753"},{"isin":"CH0210483332","time":"2026-09-09T09:34:48Z","title":"RBC belässt Richemont auf 'Outperform'","id":"20260909586692"},{"isin":"CH0012005267","time":"2026-09-09T07:39:20Z","title":"Deutsche Bank senkt Novartis auf 'Hold' und Ziel auf 120 Franken","id":"20260909586686"},{"isin":"CH0012005267","time":"2026-09-08T21:38:59Z","title":"RBC startet Novartis mit 'Sector Perform' - Ziel 120 Franken","id":"20260908586661"},{"isin":"CH0038863350","time":"2026-09-08T17:18:58Z","title":"JPMorgan belässt Nestle auf 'Neutral' - Ziel 90 Franken","id":"20260908586653"},{"isin":"CH0012005267","time":"2026-09-08T08:10:19Z","title":"Deutsche Bank Research belässt Novartis auf 'Buy'","id":"20260908586635"},{"isin":"CH0012005267","time":"2026-09-08T07:39:46Z","title":"Jefferies belässt Novartis auf 'Hold' - Ziel 110 Franken","id":"20260908586634"},{"isin":"CH0012005267","time":"2026-09-08T06:16:06Z","title":"Barclays hebt Ziel für Novartis auf 130 Franken - 'Equal Weight'","id":"20260908586627"},{"isin":"CH0244767585","time":"2026-09-08T04:31:46Z","title":"JPMorgan hebt Ziel für UBS auf 50 Franken - 'Overweight'","id":"20260908586608"},{"isin":"CH0038863350","time":"2026-09-07T14:58:58Z","title":"Bernstein belässt Nestle auf 'Market-Perform' - Ziel 74 Franken","id":"20260907586601"},{"isin":"CH0012005267","time":"2026-09-07T04:43:36Z","title":"Jefferies belässt Novartis auf 'Hold' - Ziel 110 Franken","id":"20260907586579"},{"isin":"CH0126881561","time":"2026-09-04T08:52:58Z","title":"RBC belässt Swiss Re auf 'Underperform' - Ziel 115 Franken","id":"20260904586560"},{"isin":"CH0126881561","time":"2026-09-04T08:25:32Z","title":"Barclays hebt Ziel für Swiss Re auf 123 Franken - 'Underweight'","id":"20260904586557"},{"isin":"CH0012005267","time":"2026-09-04T05:38:55Z","title":"Jefferies belässt Novartis auf 'Hold' - Ziel 110 Franken","id":"20260904586539"},{"isin":"CH0010645932","time":"2026-09-03T07:59:09Z","title":"Deutsche Bank Research hebt Ziel für Givaudan - 'Buy'","id":"20260903586511"},{"isin":"CH0038863350","time":"2026-09-02T06:27:39Z","title":"UBS belässt Nestle auf 'Neutral' - Ziel 80 Franken","id":"20260902586474"},{"isin":"CH0038863350","time":"2026-09-02T06:27:18Z","title":"JPMorgan belässt Nestle auf 'Neutral' - Ziel 90 Franken","id":"20260902586473"},{"isin":"CH0012005267","time":"2026-09-01T22:01:37Z","title":"Deutsche Bank Research lässt Novartis auf 'Buy', Ziel 140 Franken","id":"20260902586482"},{"isin":"CH0012005267","time":"2026-09-01T09:33:03Z","title":"UBS belässt Novartis auf 'Neutral' - Ziel 116 Franken","id":"20260901586456"},{"isin":"CH0012005267","time":"2026-09-01T09:12:07Z","title":"Jefferies belässt Novartis auf 'Hold' - Ziel 110 Franken","id":"20260901586449"},{"isin":"CH0010645932","time":"2026-09-01T09:06:20Z","title":"JPMorgan belässt Givaudan auf 'Overweight'","id":"20260901586446"},{"isin":"CH0010645932","time":"2026-09-01T04:39:16Z","title":"Jefferies senkt Givaudan auf 'Hold' - Ziel auf 3030 Franken","id":"20260901586429"},{"isin":"CH0244767585","time":"2026-08-31T21:28:59Z","title":"RBC belässt UBS auf 'Outperform' - Ziel 44 Franken","id":"20260831586426"},{"isin":"CH0244767585","time":"2026-08-31T19:48:58Z","title":"Jefferies belässt UBS auf 'Buy' - Ziel 60 Franken","id":"20260831586424"},{"isin":"CH0012005267","time":"2026-08-28T06:34:25Z","title":"Deutsche Bank Research lässt Novartis auf 'Buy', Ziel 140 Franken","id":"20260828586412"},{"isin":"CH0010645932","time":"2026-08-28T05:05:58Z","title":"Bernstein belässt Givaudan auf 'Underperform' - Ziel 2886 Franken","id":"20260828586406"},{"isin":"CH0010645932","time":"2026-08-28T05:05:33Z","title":"JPMorgan belässt Givaudan auf 'Overweight' - Ziel 3600 Franken","id":"20260828586405"},{"isin":"CH0012005267","time":"2026-08-25T07:02:38Z","title":"Deutsche Bank Research lässt Novartis auf 'Buy'","id":"20260825586328"},{"isin":"CH0012221716","time":"2026-08-21T05:24:52Z","title":"Bernstein belässt ABB auf 'Market-Perform' - Ziel 80 Franken","id":"20260821586267"},{"isin":"CH0210483332","time":"2026-08-20T09:29:25Z","title":"Bernstein belässt Richemont auf 'Outperform' - Ziel 240 Franken","id":"20260820586245"},{"isin":"CH0038863350","time":"2026-08-20T09:06:09Z","title":"Bernstein belässt Nestle auf 'Market-Perform' - Ziel 74 Franken","id":"20260820586234"},{"isin":"CH0012005267","time":"2026-08-19T08:12:05Z","title":"Deutsche Bank Research lässt Novartis auf 'Buy', Ziel 140 Franken","id":"20260819586198"},{"isin":"CH0010645932","time":"2026-08-18T06:07:07Z","title":"Bernstein belässt Givaudan auf 'Underperform' - Ziel 2886 Franken","id":"20260818586159"},{"isin":"CH0244767585","time":"2026-08-18T04:38:51Z","title":"JPMorgan belässt UBS auf 'Overweight' - Ziel 46 Franken","id":"20260818586143"},{"isin":"CH0126881561","time":"2026-08-17T12:01:15Z","title":"Jefferies belässt Swiss Re auf 'Hold' - Ziel 130 Franken","id":"20260817586130"},{"isin":"CH0011075394","time":"2026-08-17T12:01:15Z","title":"Jefferies belässt Zurich auf 'Hold' - Ziel 520 Franken","id":"20260817586129"},{"isin":"CH0038863350","time":"2026-08-17T09:35:01Z","title":"JPMorgan belässt Nestle auf 'Neutral' - Ziel 90 Franken","id":"20260817586115"},{"isin":"CH0210483332","time":"2026-08-16T22:45:42Z","title":"Bernstein belässt Richemont auf 'Outperform' - Ziel 240 Franken","id":"20260817586125"},{"isin":"CH0012221716","time":"2026-08-13T05:48:16Z","title":"Bernstein hebt Ziel für ABB auf 80 Franken - 'Market-Perform'","id":"20260813585956"},{"isin":"CH0012221716","time":"2026-08-11T22:56:56Z","title":"Bernstein belässt ABB auf 'Market-Perform' - Ziel 70 Franken","id":"20260812585925"},{"isin":"CH0126881561","time":"2026-08-11T17:01:15Z","title":"JPMorgan belässt Swiss Re auf 'Underweight' - Ziel 125 Franken","id":"20260811585839"},{"isin":"CH0244767585","time":"2026-08-10T08:48:55Z","title":"Goldman hebt Ziel für UBS auf 47 Franken - 'Neutral'","id":"20260810585775"},{"isin":"CH0010645932","time":"2026-08-10T06:12:43Z","title":"Bernstein belässt Givaudan auf 'Underperform' - Ziel 2886 Franken","id":"20260810585756"},{"isin":"CH0012005267","time":"2026-08-10T05:19:24Z","title":"JPMorgan belässt Novartis auf 'Overweight' - Ziel 135 Franken","id":"20260810585746"},{"isin":"CH0011075394","time":"2026-08-07T09:48:11Z","title":"RBC senkt Ziel für Zurich auf 650 Franken - 'Outperform'","id":"20260807585685"},{"isin":"CH0126881561","time":"2026-08-06T07:44:07Z","title":"RBC belässt Swiss Re nach Zahlen auf 'Underperform'","id":"20260806585553"},{"isin":"CH0011075394","time":"2026-08-06T06:27:06Z","title":"RBC belässt Zurich auf 'Outperform' - Ziel 670 Franken","id":"20260806585532"},{"isin":"CH0126881561","time":"2026-08-06T06:26:41Z","title":"Jefferies belässt Swiss Re auf 'Hold' - Ziel 130 Franken","id":"20260806585531"},{"isin":"CH0126881561","time":"2026-08-06T06:26:20Z","title":"JPMorgan belässt Swiss Re auf 'Underweight' - Ziel 125 Franken","id":"20260806585530"},{"isin":"CH0011075394","time":"2026-08-06T05:56:32Z","title":"Jefferies belässt Zurich auf 'Hold' - Ziel 520 Franken","id":"20260806585528"},{"isin":"CH0126881561","time":"2026-08-05T22:31:57Z","title":"UBS belässt Swiss Re nach Zahlen auf 'Sell'","id":"20260806585588"},{"isin":"CH0244767585","time":"2026-08-05T05:31:05Z","title":"RBC hebt Ziel für UBS auf 44 Franken - 'Outperform'","id":"20260805585415"},{"isin":"CH0038863350","time":"2026-08-05T05:11:31Z","title":"Jefferies belässt Nestle auf 'Buy' - Ziel 99 Franken","id":"20260805585407"},{"isin":"CH0011075394","time":"2026-08-04T22:30:07Z","title":"Jefferies belässt Zurich nach Beazley-Zahlen auf 'Hold'","id":"20260805585468"},{"isin":"CH0244767585","time":"2026-07-31T14:31:15Z","title":"JPMorgan hebt Ziel für UBS auf 46 Franken - 'Overweight'","id":"20260731585198"},{"isin":"CH0038863350","time":"2026-07-31T09:12:24Z","title":"Bernstein belässt Nestle auf 'Market-Perform' - Ziel 74 Franken","id":"20260731585146"},{"isin":"CH0244767585","time":"2026-07-30T14:21:16Z","title":"DZ Bank hebt fairen Wert für UBS auf 49 Franken - 'Kaufen'","id":"20260730585099"},{"isin":"CH0010645932","time":"2026-07-29T13:11:15Z","title":"DZ Bank senkt fairen Wert für Givaudan - 'Halten'","id":"20260729584937"},{"isin":"CH0244767585","time":"2026-07-28T22:38:13Z","title":"RBC belässt UBS nach Zahlen auf 'Outperform'","id":"20260729584902"},{"isin":"CH0244767585","time":"2026-07-28T22:36:58Z","title":"JPMorgan belässt UBS nach Zahlen auf 'Overweight'","id":"20260729584900"},{"isin":"CH0126881561","time":"2026-07-28T05:56:12Z","title":"JPMorgan senkt Swiss Re auf 'Underweight' mit Ziel 125 Franken","id":"20260728584781"},{"isin":"CH0038863350","time":"2026-07-27T18:41:15Z","title":"JPMorgan belässt Nestle auf 'Neutral' - Ziel 90 Franken","id":"20260727584775"},{"isin":"CH0012005267","time":"2026-07-27T12:01:15Z","title":"Berenberg hebt Ziel für Novartis auf 120 Franken - 'Hold'","id":"20260727584750"},{"isin":"CH0010645932","time":"2026-07-27T08:25:43Z","title":"Deutsche Bank Research hebt Ziel für Givaudan an - 'Buy'","id":"20260727584730"},{"isin":"CH0038863350","time":"2026-07-24T13:20:44Z","title":"Deutsche Bank belässt Nestle auf 'Hold' - Ziel 82 Franken","id":"20260724584695"},{"isin":"CH0012221716","time":"2026-07-24T09:28:52Z","title":"Deutsche Bank Research hebt Ziel für ABB auf 74 Franken - 'Hold'","id":"20260724584668"},{"isin":"CH0010645932","time":"2026-07-24T08:46:56Z","title":"JPMorgan belässt Givaudan auf 'Overweight' - Ziel 3600 Franken","id":"20260724584661"},{"isin":"CH0010645932","time":"2026-07-23T22:55:47Z","title":"Deutsche Bank belässt Givaudan auf 'Buy' - Ziel 3300 Franken","id":"20260724584679"},{"isin":"CH0010645932","time":"2026-07-23T22:25:13Z","title":"Bernstein belässt Givaudan auf 'Underperform' - Ziel 2886 Franken","id":"20260724584675"},{"isin":"CH0038863350","time":"2026-07-23T09:53:05Z","title":"JPMorgan belässt Nestle auf 'Neutral' - Ziel 90 Franken","id":"20260723584606"},{"isin":"CH0010645932","time":"2026-07-23T09:38:10Z","title":"JPMorgan belässt Givaudan auf 'Overweight' - Ziel 3600 Franken","id":"20260723584601"},{"isin":"CH0038863350","time":"2026-07-23T09:24:23Z","title":"Bernstein belässt Nestle auf 'Market-Perform' - Ziel 74 Franken","id":"20260723584594"},{"isin":"CH0038863350","time":"2026-07-23T08:54:13Z","title":"Jefferies belässt Nestle auf 'Buy' - Ziel 99 Franken","id":"20260723584591"},{"isin":"CH0010645932","time":"2026-07-23T08:52:46Z","title":"Bernstein belässt Givaudan auf 'Underperform' - Ziel 2886 Franken","id":"20260723584590"},{"isin":"CH0012005267","time":"2026-07-23T08:44:49Z","title":"Jefferies belässt Novartis auf 'Hold' - Ziel 110 Franken","id":"20260723584586"},{"isin":"CH0038863350","time":"2026-07-23T08:18:08Z","title":"RBC belässt Nestle auf 'Sector Perform' - Ziel 84 Franken","id":"20260723584577"},{"isin":"CH0010645932","time":"2026-07-23T06:18:23Z","title":"Jefferies belässt Givaudan auf 'Buy' - Ziel 3700 Franken","id":"20260723584568"},{"isin":"CH0012005267","time":"2026-07-22T15:40:44Z","title":"DZ Bank hebt fairen Wert für Novartis auf 130 Franken - 'Halten'","id":"20260722584556"},{"isin":"CH0244767585","time":"2026-07-22T13:00:44Z","title":"JPMorgan belässt UBS auf 'Overweight'","id":"20260722584548"},{"isin":"CH0012005267","time":"2026-07-22T09:56:12Z","title":"JPMorgan belässt Novartis auf 'Overweight' - Ziel 135 Franken","id":"20260722584525"},{"isin":"CH0210483332","time":"2026-07-22T09:44:45Z","title":"Bernstein belässt Richemont auf 'Outperform' - Ziel 240 Franken","id":"20260722584518"},{"isin":"CH0038863350","time":"2026-07-22T06:16:14Z","title":"Jefferies hebt Nestle auf 'Buy' - Ziel erhöht auf 99 Franken","id":"20260722584490"},{"isin":"CH0038863350","time":"2026-07-21T22:18:50Z","title":"JPMorgan belässt Nestle auf 'Neutral'","id":"20260722584533"},{"isin":"CH0010645932","time":"2026-07-21T22:18:41Z","title":"JPMorgan belässt Givaudan auf 'Overweight'","id":"20260722584532"},{"isin":"CH0012005267","time":"2026-07-21T22:10:35Z","title":"Bernstein hebt Novartis-Ziel auf 132,84 Franken - 'Market-Perf.'","id":"20260722584529"},{"isin":"CH0012005267","time":"2026-07-21T22:08:43Z","title":"Deutsche Bank belässt Novartis auf 'Buy' - Ziel 140 Franken","id":"20260722584528"},{"isin":"CH0012005267","time":"2026-07-21T22:03:26Z","title":"UBS belässt Novartis auf 'Neutral' - Ziel 116 Franken","id":"20260722584526"},{"isin":"CH0010645932","time":"2026-07-21T18:10:45Z","title":"Bernstein startet Givaudan mit 'Underperform' - Ziel 2886 Franken","id":"20260721584485"},{"isin":"CH0210483332","time":"2026-07-21T07:52:29Z","title":"Deutsche Bank hebt Ziel für Richemont auf 210 Franken - 'Buy'","id":"20260721584460"},{"isin":"CH0012221716","time":"2026-07-21T07:34:22Z","title":"RBC hebt Ziel für ABB auf 83 Franken - 'Sector Perform'","id":"20260721584453"},{"isin":"CH0012005267","time":"2026-07-21T06:56:25Z","title":"Bernstein belässt Novartis auf 'Market-Perform'","id":"20260721584445"},{"isin":"CH0012005267","time":"2026-07-21T06:38:07Z","title":"Jefferies belässt Novartis auf 'Hold' - Ziel 110 Franken","id":"20260721584444"},{"isin":"CH0011075394","time":"2026-07-21T05:20:29Z","title":"RBC startet Zurich mit 'Outperform' - Ziel 670 Franken","id":"20260721584435"},{"isin":"CH0012221716","time":"2026-07-20T07:19:45Z","title":"Berenberg belässt ABB auf 'Hold' - Ziel 80 Franken","id":"20260720584409"},{"isin":"CH0012221716","time":"2026-07-17T09:45:09Z","title":"Deutsche Bank Research belässt ABB auf 'Hold' - Ziel 70 Franken","id":"20260717584384"},{"isin":"CH0012005267","time":"2026-07-17T08:29:58Z","title":"Deutsche Bank belässt Novartis auf 'Buy' - Ziel 140 Franken","id":"20260717584377"},{"isin":"CH0012221716","time":"2026-07-16T15:20:44Z","title":"DZ Bank hebt fairen Wert für ABB auf 95 Franken - 'Kaufen'","id":"20260716584348"},{"isin":"CH0012221716","time":"2026-07-16T12:50:44Z","title":"Berenberg belässt ABB auf 'Hold' - Ziel 80 Franken","id":"20260716584341"},{"isin":"CH0210483332","time":"2026-07-16T12:00:44Z","title":"Berenberg hebt Ziel für Richemont auf 170 Franken - 'Hold'","id":"20260716584339"}]}